The effect of inhaled corticosteroids on bronchoalveolar lavage interleukin-8 levels and cell percentage in stable chronic obstructive pulmonary disease patients Source: Eur Respir J 2001; 18: Suppl. 33, 212s Year: 2001
Determination of IL-8 concentration and the activity of β-glucuronidase in BAL samples in children with inflammatory lung disease Source: Annual Congress 2010 - From viral bronchiolitis to recurrent pneumonia in childhood: diagnosis, treatment and underlying factors Year: 2010
The influence of the COPD exacerbation treatment on the MMP-9 concentration in serum, induced sputum and BAL Source: Eur Respir J 2005; 26: Suppl. 49, 298s Year: 2005
The interaction between leptin and inflammatory markers in induced sputum in patients with moderate COPD Source: Eur Respir J 2002; 20: Suppl. 38, 404s Year: 2002
Dynamic of proinflammatory cytokines system and nonspecific markers of inflammation in patients with COPD before and after treatment with broncholitics Source: Eur Respir J 2006; 28: Suppl. 50, 38s Year: 2006
Effects of anti-inflammatory treatment on inflammatory infiltrate and ventilation parameters in patients with moderate COPD Source: Eur Respir J 2007; 30: Suppl. 51, 141s Year: 2007
Effect of inhaled budesonide on BAL inflammatory cells and MMP-12 expression in COPD Source: Eur Respir J 2007; 30: Suppl. 51, 611s Year: 2007
An evaluation of circulating cytokines milieu in patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 311s Year: 2002
Impact of cytokines on endothelium in COPD patients Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases Year: 2021
Effect of one moderate or mild exacerbation on lung function and serum inflammatory markers in ex smokers patients with COPD Source: Annual Congress 2009 - Cellular-tissue modifications and functional evaluation in COPD patients Year: 2009
Treatment: how does inflammatory phenotype influence response to treatment in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007
Change of induced sputum TNF-a and sTNF-R55,75 levels in patients with acute exacerbations of COPD Source: Annual Congress 2007 - Respiratory pathophysiology Year: 2007
Cytokines concentrations in induced sputum of mild COPD patients. Correlation to clinical response to inhaled corticosteroids Source: Eur Respir J 2002; 20: Suppl. 38, 309s Year: 2002
Effects of dexamethasone and anti-inflammatory drugs on inflammatory cytokines from bronchial epithelial cells of COPD patients Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015
The influence of smoking on the level of proinflammatory cytokines in patients with COPD Source: Annual Congress 2012 - Tobacco dependence and respiratory disease Year: 2012
BALF cells expression phenotypes and cytokine levels in BALF supernatant in fibrosing interstitial lung diseases Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012
Expression profiling of Th17 associated molecules in bronchoalveolar cells from patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011
The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013
MMP-9 expression and activity is incresed in the BAL of patients with acute exacerbation of COPD Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012
Measurement of in situ inflammatory cell activity in the lungs of patients with COPD or asthma Source: Eur Respir J 2002; 20: Suppl. 38, 267s Year: 2002